AMETEK, Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +20

Ametek (AME) Stock Valuation Check After Recent Momentum And Mixed Fair Value Signals - simplywall.st

AI-generated analysis

πŸ“ˆ Ametek (AME) closed at US$230.45, showing a 6.9% return over the last 90 days and a 10.2% gain year-to-date.

πŸ’° The company reports US$7.60 billion in revenue and US$1.53 billion in net income with a 1-year total shareholder return of 29.8%.

πŸ“‰ Narrative fair value models estimate AME at US$259.16, suggesting the stock is undervalued by approximately 11.1%.

πŸš€ EMG and Automation segments are inflecting upwards with destocking complete and record orders driving organic growth.

⚠️ SWS DCF model calculates a fair value of US$160.75, indicating the current price may be overvalued by roughly 43%.

πŸ” Risks include lingering weakness in semiconductor and research-exposed segments affecting overall performance.

πŸ’Ό Acquisition-heavy growth strategies face scrutiny regarding whether they will deliver expected returns on investment.

πŸ“Š Analyst forecasts utilize a 9.58% discount rate to derive the narrative fair value estimate of US$259.16.

Bullish Signals
  • Ametek is experiencing strong momentum with a 6.9% share price return over the last 90 days and a 10.2% gain year-to-date.
  • The company's EMG and Automation segments are showing inflection points with destocking complete and record orders translating to accelerating organic growth.
  • Analyst narrative models suggest Ametek is undervalued at US$230.45 compared to a fair value estimate of US$259.16, offering potential upside.
  • Strong core margin expansion is expected to enhance operating leverage and group EBITDA growth in coming quarters.
  • The company has generated a 1-year total shareholder return of 29.8%, indicating sustained investor confidence beyond short-term moves.
Risk Factors
  • An SWS DCF model estimates Ametek's intrinsic value at US$160.75, suggesting the current price of US$230.45 is significantly overvalued relative to cash flow assumptions.
  • The stock faces risks if weakness persists in semiconductor and research-exposed segments, which could impact overall revenue and profitability.
  • Acquisition-heavy growth strategies carry the risk of failing to deliver expected returns, potentially diluting shareholder value.
  • Valuation signals are mixed, with one model indicating overvaluation that contradicts the narrative fair value suggesting undervaluation.
Full Analysis
Ametek (AME) is currently trading at US$230.45, reflecting recent momentum with a 6.9% return over the last 90 days and a 10.2% gain year-to-date. The company generates US$7.60 billion in revenue and US$1.53 billion in net income. Over the past year, total shareholder returns have reached 29.8%, indicating sustained interest beyond short-term fluctuations. Valuation signals are mixed for Ametek. A narrative fair value estimate suggests the stock is undervalued at US$259.16, implying upside potential based on analyst forecasts and a 9.58% discount rate. This view relies on positive trends in the EMG and Automation segments, where destocking is complete and record orders are driving organic growth and margin expansion. However, an alternative valuation model using discounted cash flows (DCF) presents a contrasting outlook. The SWS DCF model estimates Ametek's intrinsic value at US$160.75, suggesting the current price of US$230.45 is significantly overvalued relative to cash flow assumptions. Investors must weigh these conflicting signals against risks such as weakness in semiconductor and research segments or potential underperformance from acquisition-heavy growth strategies.